scutellarin has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deep, S; Zaidi, FK | 1 |
1 other study(ies) available for scutellarin and Parkinson Disease
| Article | Year |
|---|---|
Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease.
Topics: alpha-Synuclein; Amyloid; Apigenin; Glucuronates; Humans; Molecular Docking Simulation; Parkinson Disease; Protein Aggregates; Protein Aggregation, Pathological | 2020 |